New Delhi: Drug major Cipla has asked the Narendra Modi government at the Centre to allow price hike of asthma and other respiratory drugs, citing a 300 per cent increase in production cost, News18 has learnt. In a letter written by the Mumbai-based pharma firm to the country’s drug price regulator, National Pharmaceuticals Pricing Authority, the company has highlighted the …
Drug major Cipla on Monday said it has submitted an application with the US health regulator for a generic version of GSK’s Advair Diskus, which is used in the treatment of asthma and other respiratory disorders New Delhi: Drug major Cipla on Monday said it has submitted an application with the US health regulator for a generic version of GSK’s …
)